Boston Massachusetts based Lusaris Therapeutics is raising $60,000,000.00 in New Equity Investment.
Boston, MA – According to filings with the U.S. Securities and Exchange Commission, Lusaris Therapeutics is raising $60,000,000.00 in new funding. Sources indicate as part of senior management Interim Chief Executive Officer, Andrew Levin played…